The OxyContin Case – Something for Everyone

September 25, 2007

The sellers of OxyContin recently agreed to settle government allegations of improper marketing, by entering into one of the largest monetary settlements ever entered into against a pharmaceutical company and its executives. Although the case dealt with controlled substances, it has broad implications for any company regulated by the Food and Drug Administration (FDA).